Luc Mainville
Director of Finance/CFO at CHITOGENX INC.
Net worth: 793 774 $ as of 2024-03-30
Profile
Luc Mainville is the founder of LUMA Capital LLC.
He is currently the Chief Financial Officer & Senior Vice President at ChitogenX, Inc. since 2018, the President at LUMA Life, Inc. since 2015, and the Chief Financial Officer & Senior Vice President at LSL Pharma Group, Inc. His former positions include being the President, Chief Executive Officer & Director at LAB Research, Inc. from 2006 to 2011, the President & Chief Executive Officer at Neopharm Labs, Inc. from 2012 to 2015, and the Chairman at Power Tech Corp., Inc. from 2010 to 2011.
He has also held positions such as Vice Chairman at BIOTECanada from 2010 to 2012, Chairman at BioAxone Therapeutic, Inc. in 2007, and Chairman at Zucara Therapeutics, Inc. from 2017 to 2020.
Mr. Mainville has an MBA from McGill University in 1992 and an undergraduate degree from the University of Quebec in 1987.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VALEO PHARMA INC CLASS A
3.08% | 2023-09-24 | 3,041,055 ( 3.08% ) | 380 132 $ | 2024-03-30 |
LSL PHARMA GROUP INC
1.06% | 2024-03-17 | 875,000 ( 1.06% ) | 258 125 $ | 2024-03-30 |
CHITOGENX INC
7.09% | 2023-11-08 | 3,616,678 ( 7.09% ) | 155 517 $ | 2024-03-30 |
Luc Mainville active positions
| Companies | Position | Start |
|---|---|---|
| CHITOGENX INC. | Director of Finance/CFO | 2018-09-17 |
| LSL PHARMA GROUP INC. | Director of Finance/CFO | 2023-12-03 |
| LUMA Life, Inc. | President | 2015-11-30 |
Former positions of Luc Mainville
| Companies | Position | End |
|---|---|---|
| VALEO PHARMA INC. | Director of Finance/CFO | 2023-11-19 |
Zucara Therapeutics, Inc.
 Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada. | Chairman | 2020-01-31 |
| ACERUS PHARMACEUTICALS CORPORATION | Chief Executive Officer | 2018-04-30 |
| CORREVIO PHARMA CORP. | Corporate Officer/Principal | 2016-11-30 |
Neopharm Labs, Inc.
 Neopharm Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Neopharm Labs, Inc. provides analytical laboratory testing services in collaboration with pharmaceutical, medical devices, natural health and cosmetic clients. It offers natural health products, medical marijuana to veterinary and cosmetics markets. The company was founded in 1990 and is headquartered in Blainville, Canada. | Chief Executive Officer | 2015-06-30 |
Training of Luc Mainville
| McGill University | Masters Business Admin |
| University of Quebec | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| BANGI INC. | Health Technology |
| CHITOGENX INC. | Health Technology |
| VALEO PHARMA INC. | Health Technology |
| LSL PHARMA GROUP INC. | Health Technology |
| Private companies | 18 |
|---|---|
Correvio Pharma Corp.
 Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada. | Health Technology |
LAB International, Inc.
 LAB International, Inc. Pharmaceuticals: MajorHealth Technology LAB International (LAB Pharma and LAB Research) is an integrated drug development company. LAB Pharma is focused on the growing multi-billion dollar inhalation market. Its lead product, for the treatment of breakthrough cancer pain, is a fast-acting Fentanyl formulation delivered using the Company's TAIFUN(R) dry powder inhaler platform. Its pipeline also includes therapeutics for asthma, COPD, and growth hormone deficiencies | Health Technology |
Waratah Pharmaceuticals, Inc.
 Waratah Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Part of OPKO Health, Inc., Waratah Pharmaceuticals, Inc. develops pharmaceutical products. The private company is based in Calgary, Canada. The Canadian company was founded by Susan Dana Jones. Waratah Pharmaceuticals was acquired by Transition Therapeutics, Inc., part of OPKO Health, Inc. from September 01, 2016 on January 28, 2002 for $15.46 million. | Health Technology |
LAB Research, Inc.
 LAB Research, Inc. Miscellaneous Commercial ServicesCommercial Services LAB Research, Inc. provides in-vivo non-clinical research services for the global pharmaceutical, biotechnology, agrochemical and petro-chemical industries. The company performs pre-clinical studies required for the development of drugs used in the treatment of human conditions or diseases. It offers pre-Phase I, pre-Phase II/III and other services. The company's pre-Phase I services include general toxicology, genotoxicity, safety pharmacology, bioanalytics and efficacy studies. Its pre-Phase II/III services include reproductive toxicology, carcinogenicity and absorption, distribution, metabolism and excretion studies. The company was founded in 1998 and is headquartered in Laval, Canada. | Commercial Services |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
SkyePharma Canada, Inc.
 SkyePharma Canada, Inc. Miscellaneous Commercial ServicesCommercial Services SkyePharma Canada, Inc. improves the solubility of drugs through the use of nano-particulate technology. The company is based in Verdun, Canada. SkyePharma Canada was acquired by SkyePharma Plc on March 13, 2002 for $20.01 million. | Commercial Services |
Power Tech Corp., Inc.
 Power Tech Corp., Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Power Tech Corp., Inc. engaged in the manufacture and commercialization of percussion bucket for the construction, demolition, aluminum, mining, tunnel digging, forestry, and military industries. The company was founded on March 26, 2004 and is headquartered in Terrebonne, Canada. | Producer Manufacturing |
Enobia Pharma, Inc.
 Enobia Pharma, Inc. Pharmaceuticals: MajorHealth Technology Enobia Pharma, Inc. develops therapies to treat patients with ultra-rare and life-threatening genetic metabolic bone disorders. Its lead product candidate, asfotase alfa or ENB-0040, is a treatment for hypophosphatasia—a life-threatening disease that can cause skeletal deformity, severe muscle weakness and progressive damage to vital organs. The company was founded in 1997 and is headquartered in Montreal, Canada. | Health Technology |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Health Technology |
Alethia Biotherapeutics, Inc.
 Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Alethia Biotherapeutics, Inc. discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets. The firm focuses on bone loss in acute disorders, invasive carcinomas and on cancer-associated epithelial-to-mesenchymal transition. The company was founded in 2002 by Mario Filion and Yves Cornellier and is headquartered in Montreal, Canada. | Health Technology |
BioAxone Therapeutic, Inc.
 BioAxone Therapeutic, Inc. Medical/Nursing ServicesHealth Services BioAxone Therapeutic, Inc. provides an experimental therapy for the treatment of neurological disorders. The company was founded in April 2000 by Pierre Caouette and Lisa Mckerracher and is headquartered in Montreal, Canada. | Health Services |
| URRMA Biopharma, Inc. | |
Acerus Pharmaceuticals Corp.
 Acerus Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Acerus Pharmaceuticals Corp. is a pharmaceutical company. The firm is focused on the commercialization and development of prescription products that improve patient experience, with a focus in the field of men’s health. It focuses on therapeutics for urology, andrology, and endocrinology. Its products include Estrace and Natesto. The company was founded by Bruce D. Brydon, Rolf K. Reininghaus and Mark L. Thompson on September 9, 2008 and is headquartered in Mississauga, Canada. | Health Technology |
LUMA Capital LLC
 LUMA Capital LLC Investment ManagersFinance LUMA Capital LLC provides investment advice. The private company is based in Naples, FL. The company was founded by Luc Mainville. | Finance |
Neopharm Labs, Inc.
Neopharm Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Neopharm Labs, Inc. provides analytical laboratory testing services in collaboration with pharmaceutical, medical devices, natural health and cosmetic clients. It offers natural health products, medical marijuana to veterinary and cosmetics markets. The company was founded in 1990 and is headquartered in Blainville, Canada. | Commercial Services |
AAA Medic Montreal, Inc.
 AAA Medic Montreal, Inc. Agricultural Commodities/MillingProcess Industries AAA Medic Montreal, Inc. engages in production, cultivation and distribution of medicinal cannabis. The company was founded by Renaud Adams and is headquartered in Montreal, Canada. | Process Industries |
Zucara Therapeutics, Inc.
Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zucara Therapeutics, Inc. develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people. The company is headquartered in Toronto, Canada. | Health Technology |
| LUMA Life, Inc. |
- Stock Market
- Insiders
- Luc Mainville
